Clinical Observation for TCM Combined Rehabilitation Therapy for Relieving Type 2 Diabetes Mellitus Based on the Thought of Regulating and Supplementing

Not Applicable

Recruiting

• Conditions: Type 2 diabetes

• Registration Number: ITMCTR1900002357
• Lead Sponsor: Dongzhimen Hospital of Beijing University of Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

(1) Aged 18-60 years old;
(2) Clinically diagnosed with Type 2 diabetes mellitus with a course of less than 8 years. Fasting blood glucose < 7 mmol/L and HbA1c < 7% after drug intervention.
(3) Presently receiving Western medicine treatment (with unlimited varieties and methods of medication).
(4) The C-peptide levels of T2DM patients receiving insulin treatment should be greater than or equal to 0.2 nmol/L (0.6 ng/mL);
(5) BMI < 25 kg/m2;
(6) Systolic blood pressure < 160 mmHg and diastolic blood pressure < 100 mmHg in patients with hypertension;
(7) Being able to follow the treatment, examination and follow-up plan;
(8) Fully understand and voluntarily sign the informed consent.

Exclusion Criteria

(1) Abnormal liver and kidney functions.
(2) Alcoholism, malignant tumors, epilepsy or mental disorders;
(3) Diabetic complications;
(4) Arrhythmia, cardiopulmonary disfunction or previous stent surgery;
(5) With a pacemaker, hearing aid or other electronic or metal components;
(6) Severe infections, infectious diseases and severe skin lesions;
(7) Pregnant women, pregnancy preparation or lactating women;
(8) Weight-loss surgery or gastrointestinal surgery;
(9) Severe pathological changes of gallbladder, thyroid, kidney and other tissues or organs after operation;
(10) Peptic ulcer;
(11) Participating in other clinical studies;
(12) Other reasons that can not cooperate with the study.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fasting C-peptide;Fasting insulin;HbA1c;Fasting blood glucose;

Secondary Outcome Measures

Name	Time	Method
SF-36 Health Survey;2 h postprandial blood glucose;